Prognostic Factors Associated with Postprogression Survival in Advanced Hepatocellular Carcinoma Patients Treated with Sorafenib Not Eligible for Second-Line Regorafenib Treatment (Q88558587)
Jump to navigation
Jump to search
scientific article published on 03 May 2018
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Prognostic Factors Associated with Postprogression Survival in Advanced Hepatocellular Carcinoma Patients Treated with Sorafenib Not Eligible for Second-Line Regorafenib Treatment |
scientific article published on 03 May 2018 |
Statements
Prognostic Factors Associated with Postprogression Survival in Advanced Hepatocellular Carcinoma Patients Treated with Sorafenib Not Eligible for Second-Line Regorafenib Treatment (English)
Teiji Kuzuya
Masatoshi Ishigami
Yoji Ishizu
Takashi Honda
Kazuhiko Hayashi
Tetsuya Ishikawa
Isao Nakano
Yoshiki Hirooka